Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 76420-244

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 76420-244). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tramadol-figure1 (Tramadol Figure1)

A line graph comparing plasma concentrations of Tramadol over 24 hours after oral administration of Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol Immediate-Release (IR) Tablets 50 mg every 6 hours. The x-axis shows time in hours, and the y-axis shows Tramadol concentration in ng/mL.*

FDA Label Image

Tramadol-figure2 (Tramadol Figure2)

A line graph comparing M1 metabolite concentration (ng/mL) over 24 hours for Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol IR Tablets 50 mg every 6 hours. The x-axis represents time in hours, and the y-axis shows M1 concentration, illustrating differences in metabolite levels between the two formulations.*

FDA Label Image

Tramadol-figure3 (Tramadol Figure3)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis,' showing the percentage of patients achieving various response thresholds by percent improvement from baseline. The graph compares five groups: Tramadol Hydrochloride Extended-Release Tablets at 100mg, 200mg, 300mg, and 400mg doses, and a placebo group. The x-axis represents response thresholds from 0 to 100 percent improvement, and the y-axis shows the percent of patients achieving response from 0 to 60 percent.*

FDA Label Image

Tramadol-figure4 (Tramadol Figure4)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 015 Arthritis Pain Intensity VAS Responder Analysis' showing percent of patients achieving response versus response threshold (percent improvement from baseline). It compares the response rates of Tramadol Hydrochloride Extended-Release Tablets with placebo across various improvement thresholds.*

FDA Label Image

Tramadol-label-100mg (Tramadol Label 100mg)

Packaging labels for Tramadol Hydrochloride Extended Release Tablets 100 mg by Enovachem Pharmaceuticals. The labels list NDC codes 76420-244-30, 76420-244-60, and 76420-244-90 for quantities of 30, 60, and 90 tablets respectively. Each label includes distribution details by Sun Pharmaceutical Industries, a description of the tablet shape as white, round, biconvex with beveled edge, and Drug Enforcement Administration classification as Schedule CIV controlled substance.*

FDA Label Image

Tramadol-label-200mg (Tramadol Label 200mg)

Labels for Tramadol HCl ER Tablets 200 mg extended-release oral tablets, manufactured by Enovachem Pharmaceuticals, distributed by Sun Pharmaceutical Industries. The labels show NDCs 76420-245-30 (30 count), 76420-245-60 (60 count), and 76420-245-90 (90 count). Each label includes storage instructions, drug status as CIV, and a QR code.*

FDA Label Image

Tramadol-label-300mg (Tramadol Label 300mg)

Label for Tramadol HCl ER Tablets, 300 mg, by Enovachem Pharmaceuticals. The label shows the NDC code 76420-246-30 and indicates a quantity of 30 tablets. It includes distributor information for Sun Pharmaceutical Industries, Inc., storage instructions, and regulatory cautions. The text specifies the tablet appearance as white, round, with a biconvex beveled edge.*

FDA Label Image

Tramadol-structure (Tramadol Structure)

Chemical structure of tramadol hydrochloride showing its molecular arrangement with aromatic ring, hydroxyl group, cyclohexane ring, and dimethylamine side chain associated with hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.